SCHEMBL374896

SCHEMBL374896

COC(=O)C(C)Oc1cc(Br)ccc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
ABCB1 P08183 1/20 0.42
ABCC1 P33527 1/20 0.42
F9 P00740 1/20 0.41
PLAU P00749 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 1/20 0.41
GBA1 P04062 1/20 0.41
MAPK1 P28482 1/20 0.41
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.39
LMNA P02545 2/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDK1 Q15118 1/20 0.38
AR P10275 1/20 0.38
PELP1 Q8IZL8 1/20 0.38
KMT2A Q03164 1/20 0.37
POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375062 1.00 ALDH1A1 (0.43) ALDH1A1ABCB1ABCC1F9PLAU
SCHEMBL531814 0.89 PDK1 (0.46) ALDH1A1ABCB1ABCC1MAPK1MAPT
SCHEMBL16851396 0.89 PDK1 (0.46) ALDH1A1ABCB1ABCC1MAPK1MAPT
SCHEMBL9203477 0.84 RAB9A (0.51) ALDH1A1F9PLAURAB9AMAPT
SCHEMBL9203475 0.84 RAB9A (0.51) ALDH1A1F9PLAURAB9AMAPT
SCHEMBL531788 0.82 ALDH1A1 (0.49) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL29509060 0.81 PDK1 (0.47) ALDH1A1ABCB1ABCC1RAB9ANPC1
SCHEMBL7481571 0.81 PDK1 (0.47) ALDH1A1ABCB1ABCC1RAB9ANPC1
SCHEMBL11439200 0.80 ALDH1A1 (0.47) ALDH1A1ABCB1ABCC1MAPK1GAA
SCHEMBL10912916 0.80 KDR (0.43) ALDH1A1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637507-B2 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase MERCK SHARP & DOHME CORP. (US) 2014-01-28 US disclosed
US-20120022057-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE SCHERING CORPORATION (US) 2012-01-26 US disclosed
EP-2408766-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE Schering Corporation (US) 2012-01-25 EP disclosed
EP-2408744-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE Schering Corporation (US) 2012-01-25 EP disclosed
US-20110319403-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE SCHERING CORPORATION (US) 2011-12-29 US disclosed
WO-2010107765-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE SCHERING CORPORATION (US) 2010-09-23 WO disclosed
WO-2010107768-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE SCHERING CORPORATION (US) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022057-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE DGAT2, DGAT1, LCAT ALDH1A1 1082/4885ABCB1 1089/4885ABCC1 1006/4885
US-20110319403-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE DGAT2, DGAT1, LCAT ALDH1A1 837/4885ABCB1 964/4885ABCC1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.